Antibody Diversity

Problemthe immune system makes over one billion different antibody proteins
In 1950s: central dogma stated DNAto RNAto protein One gene for each protein Required millions of genes just for the immune system Does not seem possible, but most scientists thought it might be Today we know the human genome is less than 30,000 genes So, what is really going on???

Current theory must account for the following known properties of antibodies

B lymphocyte development

B lymphocyte development (2)

Germ-line vs somatic-variation theories

Germ-line: stated that each antibody had its own gene.nothing special, but required billions of genes to account for numbers of antibodies Somatic-variation: some mutation and recombination created vast number of genes for antibody formation This introduced a new concept: targeted mutation or recombination of DNA: is it possible?? Paradox: how could stability be maintained in C region and diversity exist in V region?

Dreyer and Bennett

In 1965 proposed radical theory to account for diversity of antibodies Each antibody was coded for by two separate genes One for the variable region One for the constant region Combined at the DNA level and expressed single mRNA Suggested 1000s of variable region genes and only one constant region gene Close, but no cigar Most biomedical scientists did not like this idea and rejected it

Tonegawas demonstration
1976used restriction enzymes and DNA probes to show that germ cell DNA contained several smaller DNA segments compared to DNA taken from developed lymphocytes (myeloma cells)

Genes for immunoglobulin proteins are found on different chromosomes

Multigene organization of Ig genes

Kappa light chain rearrangement

Heavy chain rearrangement

Mechanism of variable region rearrangements

Each V, D and J segments of DNA are flanked by special sequences (RSSrecombination signal sequences) of two sizes Single turn and double turn sequences (each turn of DNA is 10 base pairs long) Only single turn can combine with a double turn sequence Joining rule ensures that V segment joins only with a J segment in the proper order Recombinases join segments together

P and N region nucleotide alteration adds to diversity of V region

During recombination some nucleotide bases are cut from or add to the coding regions (p nucleotides) Up to 15 or so randomly inserted nucleotide bases are added at the cut sites of the V, D and J regions (n nucleotides_ TdT (terminal deoxynucleotidyl transferase) a unique enzyme found only in lymphocytes Since these bases are random, the amino acid sequence generated by these bases will also be random

N nucleotide addition at joining segments: the addition of random bases

Randomness in joining process helps generate diversity by creating hypervariable of antigen binding site

Imprecise joining generates diversity

Some rearrangements are productive, others are non-productive: frame shift alterations are non-productive

Allelic exclusion: only one chromosome is active in any one lymphocyte

7 means of generating antibody diversity

Diversity calculations

Somatic hypermutation adds even more variability

B cell multiplication introduces additional opportunities for alterations to rearranged VJ or VDJ segments These regions are extremely susceptible to mutation compared to regular DNA, about one base in 600 is altered per two generations of dividing (expanding) lymphocyte population

Combination of heavy and light chains adds final diversity of variable region
8262 possible heavy chain combinations 320 light chain combinations Over 2 million combinations P and N nucleotide additions and subtractions multiply this by 104 Possible combinations over 1010

Location of variability occurs within CDR regions of V domains (antigen binding sites)

Class switching among constant regions: generation of IgG, IgA and IgE with same antigenic determinantsidiotypes

Synthesis, assembly and secretion of immunoglobulins

Regulation of Ig gene transcription

Each lymphocyte rearranged gene has regulatory sequences that control gene expression Promoters: initiation sites of RNA transcription Enhancers: upstream of downstream that transcription from the promoter sequence Silencers: down-regulate transcription in germline cells Gene rearrangement brings enhancer and promoter regions close together and eliminates silencer regions allowing transcription

Understanding of immunoglobulin structure and formation has opened up a new world of possibilities
Monoclonal antibodies Engineering mice with human immune systems Generating chimeric and hybrid antibodies for clinical use Abzymes: antibodies with enzyme capability